RIPK3 expression was strongly reduced in tumor samples of skin cancer (malignant melanoma, The Cancer Genome Atlas Program (TCGA)) in comparison to normal control skin samples (Figure 1b). This evidence concerns the gene RIPK3 and skin neoplasm.